Medtronic plc (MDT)

Medtronic plc, headquartered in Galway, Ireland, is a global healthcare technology leader founded in 1949, serving healthcare systems, physicians, and patients in more than 150 countries. Guided by its founding mission to alleviate pain, restore health, and extend life through biomedical engineering, the company is pursuing a strategy centered on accelerating innovation-driven growth, delivering superior patient and provider outcomes, and leveraging data, AI, and automation. Medtronic operates through four reportable segments.

The Cardiovascular Portfolio includes Cardiac Rhythm & Heart Failure (pacemakers, ICDs, CRT devices, cardiac ablation systems, insertable monitors, and infection-prevention products), Structural Heart & Aortic (transcatheter and surgical heart valves, stent grafts, and pulmonary valve systems), and Coronary & Peripheral Vascular (coronary stents, angioplasty products, renal denervation systems, and venous disease treatments). The Neuroscience Portfolio encompasses Cranial & Spinal Technologies (spinal implants, navigation and robotic guidance systems, and biologics), Specialty Therapies (neurovascular stroke treatments, ENT products, and pelvic health devices), and Neuromodulation (spinal cord stimulators, brain modulation devices for Parkinson’s and related disorders, drug infusion systems, and interventional pain products). The Medical Surgical Portfolio covers Surgical & Endoscopy (advanced stapling, energy devices, robotic-assisted surgery via the Hugo system, hernia repair products, and endoscopy technologies) and Acute Care & Monitoring (patient monitoring, oximetry, and airway management products).

The Diabetes Operating Unit offers insulin pumps, continuous glucose monitoring systems, and smart insulin pen technology; in May 2025, Medtronic announced plans to separate this business into an independent, publicly traded company within 18 months. The company employs over 95,000 full-time employees globally, with 44% based in the U.S. or Puerto Rico, and emphasizes workforce development, pay equity, and employee engagement initiatives. Medtronic invests heavily in R&D to sustain technological leadership, relies on a broad intellectual property portfolio, and distributes products through direct sales forces and independent distributors, with the U.S., Western Europe, China, and Japan as its largest markets.

The company operates in a highly competitive, rapidly evolving medical technology industry shaped by regulatory requirements, reimbursement pressures, and consolidation among healthcare providers, and it is not dependent on any single customer for more than 10% of total net sales.